The brief remaining window until September 30, combined with Republican majorities in Congress and the absence of active constitutional processes capable of removing a president on such short notice, underpins the strong trader consensus reflected in current pricing. President Trump continues routine executive actions, including recent funding resolutions and foreign policy measures related to ongoing Middle East developments, with no verified health events, resignation signals, or Senate-level momentum for conviction following the August introduction of impeachment articles in the House. Historical patterns show that even successful House impeachments require extended Senate trials unlikely to conclude before month-end. Late developments such as a sudden medical incapacity triggering the 25th Amendment or an unforeseen bipartisan resignation agreement remain the primary theoretical paths that could alter the outcome, though both lack supporting indicators at present.